Stockreport

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says [CNBC]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF That's according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk's Wegovy and [Read more]